DK1800664T3 - Farmaceutiske formuleringer til parenteral indgivelse indeholdende epothilon - Google Patents

Farmaceutiske formuleringer til parenteral indgivelse indeholdende epothilon

Info

Publication number
DK1800664T3
DK1800664T3 DK07102856T DK07102856T DK1800664T3 DK 1800664 T3 DK1800664 T3 DK 1800664T3 DK 07102856 T DK07102856 T DK 07102856T DK 07102856 T DK07102856 T DK 07102856T DK 1800664 T3 DK1800664 T3 DK 1800664T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical formulations
parenteral administration
administration containing
epothilone
containing epothilone
Prior art date
Application number
DK07102856T
Other languages
English (en)
Inventor
Hoogevest Peter Van
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10826504&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1800664(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from PCT/EP1999/000702 external-priority patent/WO1999039694A2/en
Application granted granted Critical
Publication of DK1800664T3 publication Critical patent/DK1800664T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK07102856T 1998-02-05 1999-02-03 Farmaceutiske formuleringer til parenteral indgivelse indeholdende epothilon DK1800664T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9802451.6A GB9802451D0 (en) 1998-02-05 1998-02-05 Organic compounds
PCT/EP1999/000702 WO1999039694A2 (en) 1998-02-05 1999-02-03 Compositions containing organic compounds

Publications (1)

Publication Number Publication Date
DK1800664T3 true DK1800664T3 (da) 2009-07-20

Family

ID=10826504

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07102856T DK1800664T3 (da) 1998-02-05 1999-02-03 Farmaceutiske formuleringer til parenteral indgivelse indeholdende epothilon

Country Status (9)

Country Link
EP (1) EP1800664B8 (da)
AT (1) ATE427736T1 (da)
CY (1) CY1109190T1 (da)
DE (1) DE69940708D1 (da)
DK (1) DK1800664T3 (da)
ES (1) ES2324376T3 (da)
GB (1) GB9802451D0 (da)
PT (1) PT1800664E (da)
ZA (1) ZA99874B (da)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4138042C2 (de) * 1991-11-19 1993-10-14 Biotechnolog Forschung Gmbh Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel
JP4183099B2 (ja) * 1995-11-17 2008-11-19 ゲゼルシャフト・フュア・ビオテヒノロジッシェ・フォルシュング・ミット・ベシュレンクテル・ハフツング(ゲー・ベー・エフ) エポチロンcおよびd、製造法ならびに組成物
CN1304058C (zh) * 1996-03-12 2007-03-14 Pg-Txl有限公司 水溶性紫杉醇产品
US6441186B1 (en) * 1996-12-13 2002-08-27 The Scripps Research Institute Epothilone analogs
TR200002299T2 (tr) * 1998-02-05 2000-11-21 Novartis Ag Epotilon kompozisyonları.

Also Published As

Publication number Publication date
CY1109190T1 (el) 2014-07-02
ATE427736T1 (de) 2009-04-15
ZA99874B (en) 1999-08-05
EP1800664B1 (en) 2009-04-08
DE69940708D1 (de) 2009-05-20
EP1800664B8 (en) 2010-12-15
GB9802451D0 (en) 1998-04-01
ES2324376T3 (es) 2009-08-05
PT1800664E (pt) 2009-07-10
EP1800664A1 (en) 2007-06-27

Similar Documents

Publication Publication Date Title
MY125921A (en) Compositions containing organic compounds
DK0839026T3 (da) Micellære polyether-blokcopolymerkompositioner til målretning af biologiske midler
NO980081D0 (no) Farmasöytiske preparater
CY1110547T1 (el) Συμπυκνωμενα πρωτεϊνικα σκευασματα μειωμενου ιξωδους
GEP20053473B (en) High Potency Dihydroergotamine Compositions
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
DK0703786T3 (da) Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
NO20014035L (no) System for oral administrasjon av medikament
DE60019334D1 (de) Antivirale arznei
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
MA26802A1 (fr) Derives de streptogramine, leur preparation et les compositions qui les contiennent.
MXPA03005221A (es) Composicion farmaceutica de dronedarona para administracion parenteral.
WO2000003724A1 (en) Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient
ATE187890T1 (de) Ligandgerichtete enzyme-prodrug therapie
DK1800664T3 (da) Farmaceutiske formuleringer til parenteral indgivelse indeholdende epothilon
NO20014692D0 (no) 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav
ATE208627T1 (de) Orale zusammensetzungen mit niedrigdosierten zytotoxischen proteinen
DK0695303T3 (da) Hidtil ukendte pyridiniumsalte og deres anvendelse til bekæmpelse af Helicobacter-bakterier
SE9803107D0 (sv) Novel Compunds
DZ3204A1 (fr) Dérives de streptogramines, leur préparation et l es compositions qui les contiennent.
WO1999051253A3 (en) Immune response modulation
ECSP992852A (es) Compuestos organicos
FR2652266B1 (fr) Vaccin protecteur contre l'hemophilose porcine.
WO2000041482A3 (en) Oral administration of taxoid derivatives
SE9803277D0 (sv) Novel compounds